Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1987 1
1992 1
1994 6
1995 7
1996 10
1997 11
1998 4
1999 7
2000 7
2001 5
2002 2
2003 2
2004 1
2005 3
2006 3
2007 1
2008 1
2009 3
2010 4
2011 5
2012 5
2013 4
2014 4
2015 2
2016 1
2017 2
2018 2
2019 2
2020 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Anti-bacterial Monoclonal Antibodies.
Nagy E, Nagy G, Power CA, Badarau A, Szijártó V. Nagy E, et al. Among authors: power ca. Adv Exp Med Biol. 2017;1053:119-153. doi: 10.1007/978-3-319-72077-7_7. Adv Exp Med Biol. 2017. PMID: 29549638 Review.
Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines.
Bhusal RP, Eaton JRO, Chowdhury ST, Power CA, Proudfoot AEI, Stone MJ, Bhattacharya S. Bhusal RP, et al. Among authors: power ca. Trends Biochem Sci. 2020 Feb;45(2):108-122. doi: 10.1016/j.tibs.2019.10.003. Epub 2019 Nov 1. Trends Biochem Sci. 2020. PMID: 31679840 Free PMC article. Review.
Targeting chemokines: Pathogens can, why can't we?
Proudfoot AE, Bonvin P, Power CA. Proudfoot AE, et al. Among authors: power ca. Cytokine. 2015 Aug;74(2):259-67. doi: 10.1016/j.cyto.2015.02.011. Epub 2015 Mar 6. Cytokine. 2015. PMID: 25753743 Review.
Chemokine blockers--therapeutics in the making?
Wells TN, Power CA, Shaw JP, Proudfoot AE. Wells TN, et al. Among authors: power ca. Trends Pharmacol Sci. 2006 Jan;27(1):41-7. doi: 10.1016/ Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310864 Review.
From bench to bedside: immunotherapy for prostate cancer.
Tse BW, Jovanovic L, Nelson CC, de Souza P, Power CA, Russell PJ. Tse BW, et al. Among authors: power ca. Biomed Res Int. 2014;2014:981434. doi: 10.1155/2014/981434. Epub 2014 Sep 4. Biomed Res Int. 2014. PMID: 25276838 Free PMC article. Review.
Strategies for chemokine antagonists as therapeutics.
Proudfoot AE, Power CA, Rommel C, Wells TN. Proudfoot AE, et al. Among authors: power ca. Semin Immunol. 2003 Feb;15(1):57-65. doi: 10.1016/s1044-5323(02)00128-8. Semin Immunol. 2003. PMID: 12495641 Review.
Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE, Power CA, Schwarz MK. Proudfoot AE, et al. Among authors: power ca. Expert Opin Investig Drugs. 2010 Mar;19(3):345-55. doi: 10.1517/13543780903535867. Expert Opin Investig Drugs. 2010. PMID: 20113217 Review.
Selectivity and antagonism of chemokine receptors.
Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung CW, Peitsch MC, Proudfoot AE. Wells TN, et al. Among authors: power ca. J Leukoc Biol. 1996 Jan;59(1):53-60. doi: 10.1002/jlb.59.1.53. J Leukoc Biol. 1996. PMID: 8558067 Review.
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.
Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. Bachelerie F, et al. Among authors: power ca. Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014. Pharmacol Rev. 2013. PMID: 24218476 Free PMC article. Review.
103 results